The Impact of COVID-19 is included in Leukemia Therapeutics Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Leukemia Therapeutics Trends and Forecast
The future of the global leukemia therapeutics market looks promising with opportunities in the hospital pharmacies, drug store and retail pharmacies, and online provider markets. The global leukemia therapeutics market is expected to reach an estimated $21.46 billion by 2030 with a CAGR of 8.4% from 2024 to 2030. The major drivers for this market are growing incidence of leukemia, increasing need for more effective treatment for lukemia and rising R&D spending in the healthcare industry.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Leukemia Therapeutics by Segment
The study includes a forecast for the global leukemia therapeutics by type, drug, distribution channel, and region.
Leukemia Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Acute Lymphocytic Leukemia
• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Others
Leukemia Therapeutics Market by Drug [Shipment Analysis by Value from 2018 to 2030]:
• Chemotherapy
• Targeted Therapy and Immunotherapy
Leukemia Therapeutics Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacies
• Drug Store and Retail Pharmacies
• Online Providers
Leukemia Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Leukemia Therapeutics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies leukemia therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the leukemia therapeutics companies profiled in this report include-
• Bristol-Myers Squibb
• Takeda Pharmaceutical
• Lupin
• Gilead Sciences
• Novartis
• Amgen
• Teva Pharmaceutical Industries
• Abbvie
• Pfizer
• Sanofi
Leukemia Therapeutics Market Insights
Lucintel forecasts that chronic lymphocytic leukemia will remain the largest segment over the forecast period due to increase in product approvals for chronic lymphocytic leukemia and presence of leukemia therapeutics for chronic lymphocytic leukemia.
Within this market, hospital pharmacies will remain the largest segment due to growing public awareness regarding leukemia and its treatment options along with increasing number of people seeking treatment in hospitals.
North America is expected to witness highest growth over the forecast period due to growing research in the field of regenerative medicine for the treatment of leukemia and rising awareness on personalized medicine in the region.
Features of the Global Leukemia Therapeutics Market
Market Size Estimates: Leukemia therapeutics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Leukemia therapeutics market size by type, drug, distribution channel, and region in terms of value ($B).
Regional Analysis: Leukemia therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, drugs, distribution channels, and regions for the leukemia therapeutics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the leukemia therapeutics market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the leukemia therapeutics market size?
Answer: The global leukemia therapeutics market is expected to reach an estimated $21.46 billion by 2030.
Q.2 What is the growth forecast for leukemia therapeutics market?
Answer: The global leukemia therapeutics market is expected to grow with a CAGR of 8.4% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the leukemia therapeutics market?
Answer: The major drivers for this market are growing incidence of leukemia, increasing need for more effective treatment for lukemia and rising R&D spending in the healthcare industry.
Q4. What are the major segments for leukemia therapeutics market?
Answer: The future of the leukemia therapeutics market looks promising with opportunities in the hospital pharmacies, drug store and retail pharmacies, and online provider markets.
Q5. Who are the key leukemia therapeutics market companies?
Answer: Some of the key leukemia therapeutics companies are as follows:
• Bristol-Myers Squibb
• Takeda Pharmaceutical
• Lupin
• Gilead Sciences
• Novartis
• Amgen
• Teva Pharmaceutical Industries
• Abbvie
• Pfizer
• Sanofi
Q6. Which leukemia therapeutics market segment will be the largest in future?
Answer: Lucintel forecasts that chronic lymphocytic leukemia will remain the largest segment over the forecast period due to increase in product approvals for chronic lymphocytic leukemia and presence of leukemia therapeutics for chronic lymphocytic leukemia.
Q7. In leukemia therapeutics market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to growing research in the field of regenerative medicine for the treatment of leukemia and rising awareness on personalized medicine in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the leukemia therapeutics market by type (acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia,chronic myeloid leukemia, and others), drug (chemotherapy, and targeted therapy & immunotherapy), distribution channel (hospital pharmacies, drug store and retail pharmacies, and online providers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Leukemia Therapeutics Market, Leukemia Therapeutics Market Size, Leukemia Therapeutics Market Growth, Leukemia Therapeutics Market Analysis, Leukemia Therapeutics Market Report, Leukemia Therapeutics Market Share, Leukemia Therapeutics Market Trends, Leukemia Therapeutics Market Forecast, Leukemia Therapeutics Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Leukemia Therapeutics Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Leukemia Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Leukemia Therapeutics Market by Type
3.3.1: Acute Lymphocytic Leukemia
3.3.2: Acute Myeloid Leukemia
3.3.3: Chronic Lymphocytic Leukemia
3.3.4: Chronic Myeloid Leukemia
3.3.5: Others
3.4: Global Leukemia Therapeutics Market by Drug
3.4.1: Chemotherapy
3.4.2: Targeted Therapy and Immunotherapy
3.5: Global Leukemia Therapeutics Market by Distribution channel
3.5.1: Hospital Pharmacies
3.5.2: Drug Store and Retail Pharmacies
3.5.3: Online Providers
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Leukemia Therapeutics Market by Region
4.2: North American Leukemia Therapeutics Market
4.2.2: North American Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
4.3: European Leukemia Therapeutics Market
4.3.1: European Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
4.3.2: European Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
4.4: APAC Leukemia Therapeutics Market
4.4.1: APAC Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
4.4.2: APAC Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
4.5: ROW Leukemia Therapeutics Market
4.5.1: ROW Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
4.5.2: ROW Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Leukemia Therapeutics Market by Type
6.1.2: Growth Opportunities for the Global Leukemia Therapeutics Market by Drug
6.1.3: Growth Opportunities for the Global Leukemia Therapeutics Market by Distribution channel
6.1.4: Growth Opportunities for the Global Leukemia Therapeutics Market by Region
6.2: Emerging Trends in the Global Leukemia Therapeutics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Leukemia Therapeutics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Leukemia Therapeutics Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Bristol-Myers Squibb
7.2: Takeda Pharmaceutical
7.3: Lupin
7.4: Gilead Sciences
7.5: Novartis
7.6: Amgen
7.7: Teva Pharmaceutical Industries
7.8: Abbvie
7.9: Pfizer
7.10: Sanofi
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Leukemia Therapeutics Market Report.